TMCnet News

World Molecular Diagnostics (Infectious Disease, Cancer, NAT Blood Screening, Transplantation, Histology/Cytology, Inherited Diseases) Market 2017-2021 - Research and Markets
[March 08, 2017]

World Molecular Diagnostics (Infectious Disease, Cancer, NAT Blood Screening, Transplantation, Histology/Cytology, Inherited Diseases) Market 2017-2021 - Research and Markets


Research and Markets has announced the addition of the "The World Market for Molecular Diagnostics, 7th Edition (Infectious Disease, Cancer, NAT Blood Screening, Transplantation, Histology/Cytology, Inherited Diseases)" report to their offering.

This report, The Market for Molecular Diagnostics, examines the current state for molecular assays, including cancer tests, NAT blood screening, transplantation testing, histology testing and inherited disease testing. Market size and forecasts are provided to 2021 for major segments and several subsegments. Profiles of operators and market share is provided.

Key Topics Covered:

1: Executive Summary

Molecular Diagnostic Technologies

Molecular Diagnostics In Healthcare

Global Molecular Diagnostics Market

Major Conclusions

2: Introduction To Clinical Molecular Diagnostics

Nucleic Acid Amplification Test (Naat) Technologies

Real-Time Pcr (Qpcr)

Isothermal Amplification

Trends In Nucleic Acid Amplification Testing And Emerging Technologies

Microarrays

Trends In Microarray Testing

In Situ Hybridization (Ish)

Trends In In Situ Hybridization Testing

Sequencing

Trends In Clinical Sequencing

Conclusions

3: Molecular Diagnostics In Healthcare

Reimbursement Environment For Molecular Diagnostics

Molecular Diagnostics And The Clinical Utility Standard

Laboratory-Developed Tests Are Here To Stay

Conclusions

4: Market For Moleclar Infectious Disease Diagnostics



Market Analysis

Ct/Ng, Hpv And Women's Health


Hepatitis

Hiv

Hospital-Acquired Infections (Hais) And Sepsis

Respiratory

Tuberculosis

Conclusions

5: Market For Molecular Blood Transfusion Diagnostics

Market Analysis

New Infectious Disease Threats And Assay Introduction

Conclusions

6: Market For Molecular Histology And Cytology Diagnostics

Market Analysis

Rna In Molecular Histology

Cish And Other Reagent Chemistries

Prenatal Testing Moves To Nipt

Conclusions

7: Market For Molecular Cancer Diagnostics

Introduction

Bringing Molecular Resolution To Cancer Diagnostics

Tissue-Based Diagnostics, Companion Assays And The Status Quo In Ivd

Market Analysis

Conclusions

8: Market For Molecular Transplant Diagnostics

Introduction

Market Analysis

Technological Shift To Next-Generation Sequencing And Real-Time Pcr

Conclusions

9: Market For Molecular Diagnostics In Inherited Diseases

Market Analysis

Thrombophilia And Coagulation Markers

Autism

Alzheimer's Disease

Cardiovascular Disease

Diabetes

Psychiatric Disorders

Gastrointestinal Conditions

Other Autoimmune Diseases

Conclusions

10: Molecular Diagnostics Market Summary And Major Conclusions

Market Summary

Major Conclusions

11: Company Profiles

  • Abbott Diagnostics
  • Advanced Cell Diagnostics
  • Affymetrix (Thermo Fisher Scientific)
  • Agilent (News - Alert) Technologies
  • Amoy Diagnostics
  • Applied Spectral Imaging
  • Beckman Coulter (Danaher)
  • Becton, Dickinson & Co. (Bd)
  • Berry Genomics
  • Biocartis
  • Biomérieux
  • Bio-Rad Laboratories
  • Bioview
  • Caredx
  • Cepheid (Danaher (News - Alert))
  • Covaris
  • Dako (Agilent Technologies)
  • Eiken Chemical
  • Epigenomics
  • Exosome Diagnostics
  • Genmark Diagnostics
  • Hologic
  • Illumina
  • Immucor
  • Luminex Corporation
  • Meridian Bioscience
  • Nanosphere (Luminex)
  • Nanostring Technologies
  • Qiagen
  • Quidel
  • Roche Diagnostics
  • Siemens (News - Alert) Healthcare Diagnostics
  • Thermo Fisher Scientific
  • Vela Diagnostics
  • Ventana Medical Systems (Roche)

For more information about this report visit http://www.researchandmarkets.com/research/67q5d8/the_world_market


[ Back To TMCnet.com's Homepage ]